Jiangsu Nanfang Medical Co Ltd
SSE:603880
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (2.9), the stock would be worth ¥2.56 (61% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 7.4 | ¥6.54 |
0%
|
| 3-Year Average | 2.9 | ¥2.56 |
-61%
|
| 5-Year Average | 2.9 | ¥2.52 |
-62%
|
| Industry Average | 2.3 | ¥2 |
-69%
|
| Country Average | 2.4 | ¥2.15 |
-67%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
J
|
Jiangsu Nanfang Medical Co Ltd
SSE:603880
|
1.9B CNY | 7.4 | -9.3 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.9T JPY | 9.6 | 39.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
59.4B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.2B CHF | 1.7 | 37.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
91B DKK | 6.7 | 23.2 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.2B USD | 3.1 | 30.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.2B GBP | 3.7 | 32.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
905.8B JPY | 5.7 | 51.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 0.9 | -15.4 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.2T KRW | 19.6 | -37.2 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.7B CNY | 2.1 | 22.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.4 |
| 70th Percentile | 3.9 |
| Max | 1 172 445.9 |
Other Multiples
Jiangsu Nanfang Medical Co Ltd
Glance View
Jiangsu Nanfang Medical Co., Ltd. engages in the research, development, manufacture, and sale of transdermal, medical bondage, and sports protection, first-aid kits and care products. The company is headquartered in Changzhou, Jiangsu and currently employs 1,023 full-time employees. The company went IPO on 2017-08-07. The firm is mainly engaged in research and development, manufactures and sales of transdermal products, medical tape and bandages, sports protection products, first-aid kits, nursing products and others. The Company’s main products include Band-Aid, patches, medical tapes, plaster dressings, sports protection products, first-aid kits, care products and other products. The Company’s brands include MIAO-SHOU, Oushun and others.
